JAMA · 2001 · 631 citations · 29 references
MedicineBehavioral SciencesPsychiatryBehavioral HealthBehavioral MedicineSleep MedicineCognitive Behavioral TherapyCognitive Behavioral Therapy For InsomniaInsomnia DisordersSleep DisturbanceSleep-wake DisordersChronic Insomnia TreatmentInsomnia SymptomsPlacebo-controlled Efficacy AssessmentPrimary InsomniaSleep Maintenance Insomnia TreatmentSleep Maintenance TreatmentSleep Time
Nonpharmacological behavioral therapy has been suggested for chronic primary insomnia, yet well‑blinded, placebo‑controlled trials demonstrating its efficacy for sleep‑maintenance insomnia are lacking. The study aimed to test the efficacy of a hybrid CBT compared with progressive muscle relaxation and placebo for treating primary sleep‑maintenance insomnia. A randomized, double‑blind, placebo‑controlled trial enrolled 75 adults with chronic primary sleep‑maintenance insomnia, assigning them to CBT (sleep education, stimulus control, time‑in‑bed restrictions), progressive muscle relaxation, or quasi‑desensitization. CBT led to clinically significant improvements, achieving a 54 % reduction in WASO, sleep times over 6 h, and 85.1 % efficiency, outperforming RT and placebo and sustaining benefits through 6 months.
ContextUse of nonpharmacological behavioral therapy has been suggested for treatment of chronic primary insomnia, but well-blinded, placebo-controlled trials demonstrating effective behavioral therapy for sleep-maintenance insomnia are lacking.ObjectiveTo test the efficacy of a hybrid cognitive behavioral therapy (CBT) compared with both a first-generation behavioral treatment and a placebo therapy for treating primary sleep-maintenance insomnia.Design and SettingRandomized, double-blind, placebo-controlled clinical trial conducted at a single academic medical center, with recruitment from January 1995 to July 1997.PatientsSeventy-five adults (n = 35 women; mean age, 55.3 years) with chronic primary sleep-maintenance insomnia (mean duration of symptoms, 13.6 years).InterventionsPatients were randomly assigned to receive CBT (sleep education, stimulus control, and time-in-bed restrictions; n = 25), progressive muscle relaxation training (RT; n = 25), or a quasi-desensitization (placebo) treatment (n = 25). Outpatient treatment lasted 6 weeks, with follow-up conducted at 6 months.Main Outcome MeasuresObjective (polysomnography) and subjective (sleep log) measures of total sleep time, middle and terminal wake time after sleep onset (WASO), and sleep efficiency; questionnaire measures of global insomnia symptoms, sleep-related self-efficacy, and mood.ResultsCognitive behavioral therapy produced larger improvements across the majority of outcome measures than did RT or placebo treatment. For example, sleep logs showed that CBT-treated patients achieved an average 54% reduction in their WASO whereas RT-treated and placebo-treated patients, respectively, achieved only 16% and 12% reductions in this measure. Recipients of CBT also showed a greater normalization of sleep and subjective symptoms than did the other groups with an average sleep time of more than 6 hours, middle WASO of 26.6 minutes, and sleep efficiency of 85.1%. In contrast, RT-treated patients continued to report a middle WASO of 43.3 minutes and sleep efficiency of 78.8%.ConclusionsOur results suggest that CBT represents a viable intervention for primary sleep-maintenance insomnia. This treatment leads to clinically significant sleep improvements within 6 weeks and these improvements appear to endure through 6 months of follow-up.
29
An Inventory for Measuring Depression
Aaron T. Beck · Archives of General Psychiatry · 1961 · 38.2K citations
The International Classification of Sleep Disorders
Robert B. Daroff · Neurology · 1991 · 5K citations
Glen D. Mellinger · Archives of General Psychiatry · 1985 · 1.1K citations